Vanda Pharmaceuticals | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Arrowhead Research USD 208.93M 198.86M 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Halozyme Therapeutics USD 1.51B 1.65M 2025-03
Insmed USD 1.13B 888K 2025-03
J&J USD 38.36B 7.7B 2025-03
Ligand Pharmaceuticals USD 0 0 2025-03
Merck USD 33.48B 978M 2025-03
Moderna USD 35M 4M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.64B 234M 2025-03
PTC Therapeutics USD 2.12B 179K 2024-12
Sanofi 13.41B 1.62B 2025-03
Takeda JPY 3.97T 738.36B 2025-03
Teva Pharmaceutical Industries USD 16.23B 228M 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
Veracyte USD 0 0 2025-03



Vanda Pharmaceuticals Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.